Italy at a glance
- Population
- 58.9 million 2025
- Life expectancy at birth
- 84.0 years, 2024
- People aged 65 and over
- 25.1 % of people, 2025
- Health spending per person
- 3,398 US$ per person, 2024
- Doctors
- 4.19 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
Italy Parenteral Nutrition Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$106.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $162.9 Mn | — | — |
| 2025 (base) | $171.9 Mn | +$9.0 Mn | — |
| 2026 (forecast) | $181.3 Mn | +$9.5 Mn | +5.5% |
| 2027 (forecast) | $191.3 Mn | +$10.0 Mn | +11.3% |
| 2028 (forecast) | $201.8 Mn | +$10.5 Mn | +17.4% |
| 2029 (forecast) | $212.9 Mn | +$11.1 Mn | +23.9% |
| 2030 (forecast) | $224.6 Mn | +$11.7 Mn | +30.7% |
| 2031 (forecast) | $237.0 Mn | +$12.4 Mn | +37.9% |
| 2032 (forecast) | $250.0 Mn | +$13.0 Mn | +45.5% |
| 2033 (forecast) | $263.7 Mn | +$13.7 Mn | +53.5% |
| 2034 (forecast) | $278.2 Mn | +$14.5 Mn | +61.9% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $171.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $278.2 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.5% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, setting and end user (see all) |
| Key players | Fresenius Kabi AG, Baxter International, B. Braun, ICU Medical, Otsuka Pharmaceutical Co., Ltd. (see all) |
| Regulator in Italy | AIFASource: Italian Medicines Agency (AIFA). Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Parenteral nutrition feeds patients through a vein when they cannot eat or absorb food through the gut.
Key segments of the parenteral Nutrition market include product (Amino Acids, Lipid Emulsions and Carbohydrates) and setting (Hospitals and Home Care).
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the parenteral Nutrition market.
Ready-to-use formulations, biosimilars and supply security programmes give the parenteral Nutrition market room to grow.
Drug shortages, price controls, generic competition and strict hospital budgets hold back the parenteral Nutrition market.
The parenteral Nutrition market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by AIFA, the Italian Medicines Agency, which also negotiates prices and reimbursement.[1] The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for.[2]
[1] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
[2] Italian Ministry of Health. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for parenteral Nutrition. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Italy.
What doctors and scientists are doing in Parenteral Nutrition right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Italy · 1 shared keyword
Italy · 1 shared keyword
Italy · 1 shared keyword
Italy · 1 shared keyword
Italy · 1 shared keyword
Italy
Medical Devices · Italy
OTC & Nutraceuticals · Italy
Healthcare Services · Italy
Healthcare Services · Italy
OTC & Nutraceuticals · Italy
Medical Devices · Italy